14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KILITCH.NS
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Kilitch Drugs (India) Limited
(Updated on Jun 21, 2024)

Sell candidate since Jun 18, 2024 Loss -0.18% PDF

The Kilitch Drugs (India) Limited stock price fell by -1.11% on the last day (Friday, 21st Jun 2024) from ₹328.60 to ₹324.95. During the last trading day the stock fluctuated 4.86% from a day low at ₹322.15 to a day high of ₹337.80. The price has been going up and down for this period, and there has been a 0.09% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 9 thousand shares were bought and sold for approximately ₹3.08 million.

The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.23% during the next 3 months and, with a 90% probability hold a price between ₹272.86 and ₹288.71 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KILITCH.NS Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 19, 2024, and so far it has risen 1.56%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kilitch Drugs (India) Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at ₹327.84 and ₹335.42. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Kilitch Drugs (India) Limited stock

Kilitch Drugs (India) Limited finds support from accumulated volume at ₹324.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved ₹15.65 (4.86%) between high and low. For the last week, the stock has had daily average volatility of 4.45%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KILITCH.NS) For The Upcoming Trading Day Of Monday 24th

For the upcoming trading day on Monday, 24th we expect Kilitch Drugs (India) Limited to open at ₹328.30, and during the day (based on 14 day Average True Range), to move between ₹310.31 and ₹339.59, which gives a possible trading interval of +/-₹14.64 (+/-4.51%) up or down from last closing price. If Kilitch Drugs (India) Limited takes out the full calculated possible swing range there will be an estimated 9.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at ₹324.65 (0.09%) than the resistance at ₹330.55 (1.72%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kilitch Drugs (India) Limited stock A Buy?

Kilitch Drugs (India) Limited holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.789 Sell Candidate Unchanged

Predicted Opening Price for Kilitch Drugs (India) Limited of Monday, June 24, 2024

Fair opening price June 24, 2024 Current price
₹328.30 ( 1.03%) ₹324.95

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KILITCH.NS

Fibonacci Support & Resistance Levels

Level Price
R3 343.95 5.85%
R2 337.97 4.01%
R1 334.28 2.87%
Price 324.95
S1 322.32 -0.81%
S2 318.63 -1.95%
S3 312.65 -3.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 345.90 6.45%
R2 335.80 3.34%
R1 330.55 1.72%
Price 324.95
S1 324.65 -0.0923%
S2 319.95 -1.54%
S3 0 -

KILITCH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 30, 2019 Sep 20, 2019 Oct 30, 2019 ₹0.500 0.425%
2 May 25, 2018 Sep 18, 2018 Oct 27, 2018 ₹0.500 0.327%
3 Aug 30, 2012 Sep 24, 2012 Sep 29, 2012 ₹30.00 72.29%
4 Jul 25, 2011 Aug 18, 2011 Oct 10, 2011 ₹1.00 1.25%
5 Oct 14, 2010 Oct 14, 2010 Oct 14, 2010 ₹1.00 0.85%

FAQ

What is the symbol for Kilitch Drugs (India) Limited Stock and on which exchange is it traded?
The symbol for Kilitch Drugs (India) Limited is KILITCH.NS and it is traded on the NSE (National Stock Exchange of India).

Should I buy or sell Kilitch Drugs (India) Limited Stock?
Kilitch Drugs (India) Limited holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Kilitch Drugs (India) Limited Stock?
Kilitch Drugs (India) Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kilitch Drugs (India) Limited Stock.

What's the current price of Kilitch Drugs (India) Limited Stock?
As of the end of day on the Jun 21, 2024, the price of an Kilitch Drugs (India) Limited (KILITCH.NS) share was ₹324.95.

What is the 52-week high and low for Kilitch Drugs (India) Limited Stock?
The 52-week high for Kilitch Drugs (India) Limited Stock is ₹470.00 and the 52-week low is ₹175.00.

What is the market capitalization of Kilitch Drugs (India) Limited Stock?
As of the Jun 21, 2024, the market capitalization of Kilitch Drugs (India) Limited is 5.226B.

When is the next earnings date for Kilitch Drugs (India) Limited?
The upcoming earnings date for Kilitch Drugs (India) Limited is Aug 06, 2024.
Click to get the best stock tips daily for free!

About Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, o... KILITCH.NS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT